Development
Boston Scientific Corporation
BSX
$102.83
$0.400.39%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 865.00M | 952.00M | 426.00M | 570.00M | 928.00M |
| Total Receivables | 2.23B | 2.10B | 2.13B | 2.08B | 1.97B |
| Inventory | 2.48B | 2.40B | 2.25B | 2.05B | 1.87B |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 937.00M | 1.05B | 1.08B | 1.01B | 995.00M |
| Total Current Assets | 6.51B | 6.50B | 5.89B | 5.70B | 5.76B |
|
|
|||||
| Total Current Assets | 6.51B | 6.50B | 5.89B | 5.70B | 5.76B |
| Net Property, Plant & Equipment | 3.30B | 3.08B | 2.98B | 2.88B | 2.83B |
| Long-term Investments | 14.39B | 13.61B | 13.66B | 13.27B | 12.92B |
| Goodwill | 14.39B | 13.61B | 13.66B | 13.27B | 12.92B |
| Total Other Intangibles | 6.03B | 5.89B | 6.11B | 6.12B | 5.97B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.49B | 4.53B | 4.54B | 4.54B | 4.58B |
| Total Assets | 35.14B | 34.04B | 33.60B | 32.89B | 32.47B |
|
|
|||||
| Total Accounts Payable | 942.00M | 929.00M | 899.00M | 868.00M | 862.00M |
| Total Accrued Expenses | 2.14B | 1.90B | 1.86B | 1.63B | 1.86B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 607.00M | 513.00M | 559.00M | 510.00M | 81.00M |
| Total Finance Division Other Current Liabilities | 1.25B | 1.24B | 1.25B | 1.08B | 1.01B |
| Total Other Current Liabilities | 1.25B | 1.24B | 1.25B | 1.08B | 1.01B |
| Total Current Liabilities | 4.93B | 4.58B | 4.56B | 4.08B | 3.80B |
|
|
|||||
| Total Current Liabilities | 4.93B | 4.58B | 4.56B | 4.08B | 3.80B |
| Long-Term Debt | 8.57B | 8.38B | 8.49B | 8.49B | 8.91B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 395.00M | 404.00M | 406.00M | 365.00M | 352.00M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.71B | 1.55B | 1.66B | 1.85B | 1.83B |
| Total Liabilities | 15.61B | 14.91B | 15.12B | 14.78B | 14.90B |
|
|
|||||
| Common Stock & APIC | 20.66B | 20.59B | 20.46B | 20.37B | 20.31B |
| Retained Earnings | 819.00M | 315.00M | -189.00M | -450.00M | -750.00M |
| Treasury Stock & Other | -2.20B | -2.02B | -2.04B | -2.07B | -1.98B |
| Total Common Equity | 19.28B | 18.89B | 18.23B | 17.85B | 17.57B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 19.28B | 18.89B | 18.23B | 17.85B | 17.57B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 248.00M | 243.00M | 259.00M | 259.00M | -- |
| Total Equity | 19.53B | 19.13B | 18.49B | 18.11B | 17.57B |
|
|
|||||